stockrowICON PLC
ICLR Healthcare Diagnostics & Research
ICON PLC’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.76% from fiscal 2024.
- Revenue
- −2.86%
- EPS
- +143.2%
- Free cash flow
- −8.01%
- Total debt
- −0.86%
Quarter to September 2026, against a year earlier
Follow ICLR
Alert me
ICON PLC (ICLR) Return on invested capital
ICON PLC's return on invested capital over the twelve months to 30 September 2026 was 3.84%, up 1.5 percentage points from fiscal 2025 (2.32%). Over the past ten years it has ranged from 1.86% (fiscal 2021) to 19.1% (fiscal 2015); the current reading is higher than 18% of that period. That is above the Diagnostics & Research industry median of 0.00% and above the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | 2.32% | (2.91) |
| FY2024 | 5.23% | 0.50 |
| FY2023 | 4.73% | 0.87 |
| FY2022 | 3.86% | 2.00 |
| FY2021 | 1.86% | (15.86) |
| FY2020 | 17.7% | (0.17) |
| FY2019 | 17.9% | (0.81) |
| FY2018 | 18.7% | 0.77 |
| FY2017 | 17.9% | (0.93) |
| FY2016 | 18.9% | (0.23) |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| ILMN Illumina, Inc. compare | 16.7% |
| DGX Quest Diagnostics Incorporated compare | 8.48% |
| LH Labcorp Holdings Inc. compare | 6.76% |
| QGEN QIAGEN N.V. compare | 6.62% |
| ICLR ICON PLC | 3.84% |
| RVTY Revvity Inc. compare | 2.50% |
| CRL Charles River Laboratories International, Inc. compare | 1.81% |
| MEDP Medpace Holdings, Inc. compare | 0.00% |
| GH Guardant Health, Inc. compare | −25.7% |
| Diagnostics & Research industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on ICLR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement